載入錯誤
看來載入頁面時發生了錯誤.
重新載入
我們的團隊已收到通知,但若此問題持續,請透過
電郵支援widget工具
聯絡我們。
SPRB
-38.5%
SYRS
15.1%
ONCO
13.7%
HK
前往
勁減45%
登入
觀察名單
觀點
ProPicks AI
篩選器
數據瀏覽
圖表
已儲存工作
WarrenAI
收起
Catalyst Pharmaceuticals Inc
NASDAQCM:CPRX
美國 / 保健 / 生物科技
加入觀察名單
貨幣
$
綜觀
股息
財報
模型
財務狀況
比較
穩健度
圖表
市盈率倍數
股價
24.27
USD
公允價值
18.06
USD
Metrics
Range
Conclusion
Selected LTM P/E Multiple
12.5x - 13.8x
13.1x
Selected Fwd P/E Multiple
6.7x - 7.4x
7.0x
Fair Value
$17.15 - $18.96
$18.06
Upside
-29.4% - -21.9%
-25.7%
Benchmarks
-
Full Ticker
Dyadic International, Inc.
-
NasdaqCM:DYAI
Onconetix, Inc.
-
NasdaqCM:ONCO
Cardiff Oncology, Inc.
-
NasdaqCM:CRDF
Geron Corporation
-
NasdaqGS:GERN
Trevena, Inc.
-
PINC:TRVN
Catalyst Pharmaceuticals, Inc.
-
NasdaqCM:CPRX
-
-
-
Multiples Valuation: Price / EPS
分享
儲存
股價
24.27
USD
公允價值
18.06
USD
看漲
-25.7%
Price / LTM EPS Multiple
Price / Fwd EPS Multiple
Fair Value
Benchmark Editor
Select Price / LTM EPS Ratio
Benchmark Companies
DYAI
ONCO
CRDF
GERN
TRVN
CPRX
NasdaqCM:DYAI
NasdaqCM:ONCO
NasdaqCM:CRDF
NasdaqGS:GERN
PINC:TRVN
NasdaqCM:CPRX
Historical Net Income Growth
5Y CAGR
NM-
NM-
NM-
NM-
NM-
38.7%
3Y CAGR
NM-
NM-
NM-
NM-
NM-
60.7%
Latest Twelve Months
14.5%
-182.3%
-9.6%
5.2%
-10.6%
129.5%
Historical Net Income Profit Margin
5 Year Average Margin
-404.2%
-19098.5%
-7594.3%
-23982.0%
-19680.3%
35.8%
Prior Fiscal Year
-234.4%
NA
-8496.9%
-77690.7%
12839.7%
17.9%
Latest Fiscal Year
-166.2%
-63986.5%
-6655.2%
-226.7%
-1289.2%
33.3%
Latest Twelve Months
-166.2%
-2758.7%
-6655.2%
-226.7%
-6233.7%
33.3%
Current Trading Multiples
EV / LTM EBITDA
NA
-1.3x
-1.9x
-2.9x
-0.8x
10.5x
Price / LTM Sales
10.6x
0.3x
263.5x
11.4x
2.0x
6.0x
LTM P/E Ratio
-6.4x
0.0x
-4.0x
-5.0x
0.0x
18.1x
Low
Mid
High
Benchmark LTM P/E Ratio
-6.4x
-4.0x
0.0x
Historical LTM P/E Ratio
4.8x
18.1x
28.9x
Selected P/E Multiple
12.5x
13.1x
13.8x
(x) LTM Net Income
164
164
164
(=) Equity Value
2,041
2,149
2,256
(/) Shares Outstanding
122.0
122.0
122.0
Implied Value Range
16.74
17.62
18.50
FX Rate: USD/USD
1.0
1.0
1.0
Market Price
Implied Value Range (Trading Cur)
16.74
17.62
18.50
24.29
Upside / (Downside)
-31.1%
-27.5%
-23.8%
支援算式
Equity Waterfall
Financials
Historical Multiples
Equity Value
Benchmark Companies
(in millions)
DYAI
ONCO
CRDF
GERN
TRVN
CPRX
Value of Common Equity
37
1
182
898
1
2,962
(/) Shares Outstanding
30.1
8.3
66.5
636.9
0.9
122.0
Implied Stock Price
1.22
0.07
2.74
1.41
1.28
24.29
FX Conversion Rate to Trading Currency
1.00
1.00
1.00
1.00
1.00
1.00
Implied Stock Price (Trading Cur)
1.22
0.07
2.74
1.41
1.28
24.29
Trading Currency
USD
USD
USD
USD
USD
USD
FX Rate to Reporting Currency
1.00
1.00
1.00
1.00
1.00
1.00
版權所有。
使用條款
繁體中文
English (UK)
English (India)
English (Canada)
English (Australia)
English (South Africa)
English (Philippines)
Deutsch
Español (España)
Español (México)
Français
Italiano
Nederlands
Português (Portugal)
Polski
Português (Brasil)
Русский
Türkçe
Ελληνικά
Svenska
Suomi
日本語
한국어
简体中文
Bahasa Indonesia
Bahasa Melayu
ไทย
Tiếng Việt
हिंदी
利器在握,
智勝市場
下方影音提供重點優惠總覽,助你充分利用 InvestingPro。
觀看影音教學
探索福利